SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-07-225870
Filing Date
2007-10-25
Accepted
2007-10-25 16:18:08
Documents
7
Period of Report
2007-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 1217825
2 FORM OF PERFORMANCE SHARES AGREEMENT dex101.htm EX-10.1 75293
3 CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER dex31a.htm EX-31.A 8944
4 CERTIFICATION BY CHIEF FINANCIAL OFFICER dex31b.htm EX-31.B 8639
5 CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 dex32a.htm EX-32.A 2450
6 CERTIFICATION BY THE CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 dex32b.htm EX-32.B 2459
7 GRAPHIC g18669img001.jpg GRAPHIC 12721
  Complete submission text file 0001193125-07-225870.txt   1334747
Mailing Address 345 PARK AVE NEW YORK NY 10154
Business Address 345 PARK AVE NEW YORK NY 10154 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-01136 | Film No.: 071191073
SIC: 2834 Pharmaceutical Preparations